| Bid Price | High Price | ||
| Ask Price | Low Price | ||
| Open Price | Spread | ||
| Prev Close | Volume |
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 22, 2017 | 1,164.00 | 1,192.00 | 1,135.16 | 1,188.00 | 1,284,330 |
| Aug 21, 2017 | 1,124.00 | 1,196.00 | 1,118.31 | 1,172.00 | 1,435,060 |
| Aug 18, 2017 | 1,183.00 | 1,188.00 | 1,117.00 | 1,119.00 | 1,887,193 |
| Aug 17, 2017 | 1,305.00 | 1,299.84 | 1,122.72 | 1,190.00 | 3,826,720 |
| Aug 16, 2017 | 1,324.00 | 1,350.00 | 1,315.67 | 1,329.00 | 761,168 |
| Company Name | Hikma Pharmaceuticals | Epic | HIK |
|---|---|---|---|
| ISIN | GB00B0LCW083 | Index | FTSE 250 |
| EMS | 1,000 | Prev Close | 1,188.00 |
| Shares in Issue (m) | 240.65 | Market Cap (£m) | 2,858.89 |
| PE Ratio | 17.87 | Div per Share (p) | 33.00 |
| Div Yield | 1.78 | Div Cover | 2.02 |
| EPS | 66.50 | EPS Growth (%) | -47.47 |
| PEG | -0.38 | DPS Growth (%) | 3.13 |
| ROCE | 6.10 | Net Gearing | 41.19 |
| Quick Ratio | 1.08 | Current Ratio | 1.58 |
| Date | Broker | Recomm. | Price | Old Target | New Target | Notes |
|---|---|---|---|---|---|---|
| 22 Aug | Goldman Sachs | Neutral | 1,220.50 | 2,600.00 | 1,310.00 | Downgrades |
| 21 Aug | Morgan Stanley | Equal weight | 1,220.50 | 1,600.00 | 1,350.00 | Reiterates |
| 21 Aug | Jefferies International | Hold | 1,220.50 | 1,390.00 | 1,045.00 | Upgrades |
| 21 Aug | Peel Hunt | Hold | 1,220.50 | 1,390.00 | 1,390.00 | Reiterates |
| 21 Aug | Peel Hunt | Hold | 1,220.50 | 2,150.00 | 1,390.00 | Reiterates |
| Date | Director | Type | Volume / Price | Trade Value |
|---|---|---|---|---|
| 31 May 2017 | Mazen Darwazah | Transfer In | 38,088 @ 0.00p | £0.00 |
| 31 May 2017 | Said Darwazah | Transfer In | 52,164 @ 0.00p | £0.00 |
| 15 May 2017 | Mazen Darwazah | Transfer In | 30,000 @ 0.00p | £0.00 |
| 15 May 2017 | Said Darwazah | Transfer In | 41,000 @ 0.00p | £0.00 |
| 20 Dec 2016 | Ali Al-Husry | Buy | 140,730 @ 1,827.00p | £2,571,137.10 |
